Overview

Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

Status:
RECRUITING
Trial end date:
2026-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and efficacy of Tocilizumab in MOGAD.
Phase:
PHASE2
Details
Lead Sponsor:
Tianjin Medical University General Hospital
Treatments:
Prednisone
tocilizumab